News

Food scientist and author Dr Lynne Chepulis has been appointed Research and Development Manager at honey health science company Manuka Health New Zealand Ltd.

Announcing the appointment today, Chief Executive Kerry Paul said Manuka Health is expanding R&D to advance its position in the $100 million manuka honey export industry.

“We need more in-house capability to exploit scientific advances in the uses for bee products,” he said. “Dr Chepulis is the ideal person to lead that.”

Manuka Health is the only company to certify the level of the active ingredient methylglyoxal responsible for the antibacterial activity of its MGO™ manuka honey products. It also markets non-honey bee products such as BIO30™ propolis which international researchers are investigating for its cancer-blocking properties.

Dr Chepulis returns to New Zealand from Australia’s Griffith University where she was a nutrition lecturer.
She has previous experience as a Crop and Food scientist and at Dexcel.  Her Phd at the University of Waikato’s honey research unit was a joint project with Fonterra to investigate the health advantages of honey over other sugars.

She is the author of a book “Healing Honey: A Natural Remedy for Health and Wellness” and numerous peer-reviewed publications.
Dr Chepulis will be based at Manuka Health’s Te Awamutu processing centre.